B.E.P.M. Claessen MD PhD

All Publications

 Personal Information
Surname: Claessen
First name: Bimmer
Address: Wamelplein 66
1106 DR
Amsterdam
Telephone: +31 612367600
Email: B.E.Claessen@amc.uva.nl
Nationality: Dutch
Date of birth: September 25, 1984

Current Position

2011-present Resident in cardiology (AIOS cardiologie), Academic Medical Center – University of Amsterdam (dr. RBA van den Brink)

October 2011 - September 2012: internal medicine, Academic Medical Center, University of Amsterdam (prof. dr. JBL Hoekstra)
October 2012 – March 2013: pulmonology, Flevoziekenhuis, Almere (dr. S Peters)
March 2013 - October 2013: intensive care medicine, Academic Medical Center, University of Amsterdam (prof. dr. JBL Hoekstra)
October 2013 – September 2014: cardiology, Tergooiziekenhuis Blaricum (dr. JT Keijer)
October 2014 – September 2017: cardiology, Academic Medical Center – University of Amsterdam (dr. RBA van den Brink)

Projected registration as cardiologist: October 2017

Prior Positions

2010-2011 Research Fellow, Cardiovascular Research Foundation/Center for Interventional Vascular Therapy, Columbia University Medical Center New York, NY. (supervisors prof. dr. GD Dangas, prof. R Mehran, prof. GW Stone)
2007-2010 Research Fellow, Academic Medical Center Amsterdam (supervisors prof. dr. JJ Piek, prof. dr. JGP Tijssen, dr. JPS Henriques)

Education

2011 PhD thesis: Prognostic Factors in Primary and Elective Percutaneous Coronary Intervention (University of Amsterdam, faculty of medicine, thesis advisors: prof. dr. JJ Piek, prof dr. JGP Tijssen, prof. dr. GD Dangas, dr. JPS Henriques)
2001-2007 Medical school, University Medical Center St. Radboud, Nijmegen, the Netherlands
1995-2001 Pre-university education (Gymnasium): College Sittard, the Netherlands, graduated with honors (Cum Laude)

Scientific meetings, invited faculty:

TCT: San Francisco 2011, Miami 2012, San Francisco 2013
ACC/I2 scientific sessions: Atlanta 2010, New Orleans 2011, Chicago 2012, San Francisco 2013
SCAI WIN and ACC Gender Data Forum: Washington 2012

Awards and Grants

Moderated Poster Award for the presentation: Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in Octogenarians; Trends and Outcomes from a nine-year single center experience. ESC Congress 2009, Barcelona, August 31st, 2009

Top 30 Posters for the presentation: Prognostic Impact of a Chronic Total Occlusion in a Non-Infarct Related Artery in Patients with ST-Elevation Myocardial Infarction: Three-Year Results from the HORIZONS-AMI trial TCT Conference, San Francisco, November, 2011

Research fellowship Jan 2011-July 2011 funded by research grants from Boston Scientific and Volcano Corp at the Cardiovascular Research Foundation, New York, New York, USA (directors prof dr. GD Dangas, prof. R Mehran, prof. GW Stone)

Memberships

Netherlands Society of Cardiology
European Society of Cardiology

Reviewer activities
journals
American Heart Journal
American Journal of Cardiology
BMC Cardiovascular disorders
BMJ open
Cardiology
Circulation
Circulation: Cardiovascular Interventions Diabetology and Metabolic Syndrome
EuroIntervention
European Heart Journal: Acute Cardiac Care
Heart
Indian Journal of Medical Research
The Lancet
grants
National Science Center Poland, funding scheme OPUS
abstract grader
TCT 2014

Editorial Board Membership

BMC Cardiovascular Disorders, associate editor

Publications

(Co-)Authored >60 publications in international scientific journals (24 as 1st and/or corresponding author), 2 book chapters, and >60 abstracts accepted for presentation at international scientific meetings. Attached is a detailed list scientific publications.

Hobbies and Interests

Music, playing the piano
Museums/Art
Literature
Sports (Soccer)

Publication Overview

2014

1. LP Hoebers, BEPM Claessen, GD Dangas, R Mehran, JPS Henriques. Contemporary Overview and Clinical Perspectives on Chronic Total Occlusions. Nature reviews cardiology; in press

2. A Guerchicoff, GW Stone, R Mehran , K Xu, D Nichols, BEPM Claessen, G Guagliumi, B Witzenbichler, JPS Henriques, GD Dangas. Analysis of Biomarkers for Risk of Acute Renal Insufficiency after Primary Angioplasty for Acute ST-segment Elevation Myocardial Infarction: Results of the HORIZONS-AMI Trial. Accepted for publication, Cathetherization and Cardiovascular Interventions

3. F Kiemeneij, F Yoshimachi, T Matsukage, G Amoroso G, D Fraser, BEPM Claessen, S Saito, Slender Club Europe focuses on maximal miniaturization of transradial coronary access materials and techniques: an overview and classification. Accepted for publication, EuroIntervention

4. BEPM Claessen, JPS Henriques, FA Jaffer, R Mehran, JJ Piek, GD Dangas. Stent Thrombosis: A Clinical Perspective. JACC: cardiovascular interventions, in press

5. BEPM Claessen, LP Hoebers, JPS Henriques. Coronary Chronic Total Occlusions in the Setting of Acute Myocardial Infarction. European Medical Journal – Interventional Cardiology, in press

2013

6. EP Navarese, K Tandjung, BEPM Claessen, F Andreotti, M Kowalewski, D Kandzari, D Kereiakes, R Waksman, L Mauri, I Meredith, A Fin, J Kubica, G Di Pasquale, C von Birgelen, E Kedhi. Efficacy and Safety Profile of Durable and Biodegradable Polymer Drug-Eluting Stents in Clinical Practice: Evidence from a Network Meta-Analysis of Randomized Trials. Accepted for publication: British Medical Journal (IF 17.2)

7. WJ Kikkert, LP Hoebers, P Damman, KVV Lieve, BEPM Claessen, MM Vis, J Baan, KT Koch, RJ de Winter, JJ Piek, JGP Tijssen, JPS Henriques. Recurrent Myocardial Infarction after Primary Percutaneous Coronary Intervention for Acute ST-segment Elevation Myocardial Infarction. Accepted for publication: American Journal of Cardiology (IF 3.2)

8. GD Dangas, AS Kini, SK Sharma, JPS Henriques, BEPM Claessen, SR Dixon, J Massaro, I Palacios, JJ Popma, EM Ohman, GW Stone, W O’Neill. Impact of Hemodynamic Support with Impella 2.5 versus the Intra-Aortic Balloon Pump on Prognostically Important Clinical Outcomes in Patients Undergoing High-Risk Percutaneous Coronary Intervention: Results from the PROTECT II Randomized Trial. Accepted for Publication: American Journal of Cardiology (IF 3.2)

9. TP van de Hoef, JPS Henriques, JJ Piek, BEPM Claessen. Fractional Flow Reserve Guided Percutaneous Coronary Intervention. Accepted for publication: Current Treatment Options in Cardiovascular Medicine (No IF)

10. BEPM Claessen, K Klopper, MJ Schultz. Does the Association between Mortality and Body Mass Index Weigh Heavily on the Association between a low BMI and hospital Mortality? Accepted for publication: Critical Care Medicine (IF 6.1)

11. WJ Kikkert, BEPM Claessen, GW Stone, R Mehran, B Witzenbichler, BR Brodie, J Wohrle, A Witkowski, G Guagliumi, K Zmudka, JPS Henriques, JGP Tijssen, EA Sanidas, V Chantziara, K Xu, GD Dangas. D-Dimer Levels Predict Ischemic and Hemorrhagic Outcomes after Acute Myocardial Infarction: a HORIZONS-AMI biomarker substudy Journal of Thrombosis and Thrombolysis, ePub ahead-of-print (IF 2.0)

12. LP Hoebers, BEPM Claessen, P Woudstra, WJ Kikkert, MM Vis, J Baan jr, KT Koch, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Short- and Long-Term Mortality after Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction Patients with Insulin Dependent versus Non-Insulin Depedent Diabetes Mellitus. Accepted for Publication: EuroIntervention (IF 3.2)

13. BEPM Claessen, GD Dangas, R Mehran. Balance of Ischemia and Bleeding in Selecting an Antithrombotic Regimen. Accepted for Publication: Interventional Cardiology Clinics (no IF)

14. BEPM Claessen, JPS Henriques. Antiarrhythmic, Vasoactive, and Risk-Factor Modifying Drugs in Percutaneous Coronary Intervention. Accepted for Publication: Interventional Cardiology Clinics (no IF)

15. A Caixeta, AJ Lansky, R Mehran, SJ Brener, BEPM Claessen, P Genereux, B Witzenbichler, T Palmerini, G Guagliumi, BR Brodie, D Dudek, M Fahy, GD Dangas, GW Stone. Predictors of Suboptimal TIMI Flow after Primary Angioplasty for Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial. EuroIntervention, 2013;9(2):220-7 (IF 3.2)

16. LP Hoebers, MM Vis, BEPM Claessen, RJ van der Schaaf, KD Sjauw, AE Engstrom, WJ Kikkert, J Baan, KT Koch, RJ de Winter, JJ Piek, JGP Tijssen, JPS Henriques. The Impact of Multivessel Disease with and without a Chronic Total Occlusion on Short and Long Term Mortality in Patients with and without Cardiogenic Shock. European Journal of Heart Failure, 2013;15(4):1097-105 (IF 5.2)

17. WJ Kikkert, BEPM Claessen, GW Stone, R Mehran, B Witzenbichler, B Brodie, J Wohrle, A Witkowski, G Guagliumi, K Zmudka, JPS Henriques, JGP Tijssen, K Xu, GD Dangas. Relationship between Biomarkers and Subsequent Bleeding Risk in STEMI Patients Treated with Paclitaxel-Eluting Stents: A HORIZONS-AMI substudy. Journal of Thrombosis and Thrombolysis, 2013;35(2):200-8 (IF 2.0)

18. LP Hoebers, BEPM Claessen, GD Dangas, SJ Park, JW Moses, A Colombo, JPS Henriques, GW Stone, MB Leon, R Mehran, on behalf of the multinational CTO registry. Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Elderly Patients (≥75 years): Five-Year Outcomes from a 1,791 Patient Multi-National Registry. Catheterization and Cardiovascular Interventions, 2013;82(1):85-92 (IF 2.5)

19. GD Dangas, BEPM Claessen, R Mehran, Ke XU, GW Stone. Stent Thrombosis after Primary Angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy overtime; Results of the HORIZONS-AMI trial. EuroIntervention, 2013;8(9):1033-9 (IF 3.2)

20. BEPM Claessen, GD Dangas, C Godino, A Chieffo, SW Lee, K Obunai, JPS Henriques, MB Leon, C DiMario, SJ Park, GW Stone, JW Moses, A Colombo, R Mehran, on behalf of the multinational CTO registry. Impact of Target Vessel on Long-Term Survival after Percutaneous Coronary Intervention for Chronic Total Occlusions. Catheterization and Cardiovascular Interventions, 2013;82(1);76-82 (IF 2.5)

21. WJ Kikkert, BE Claessen, N van Geloven, J Baan jr, MM Vis, KT Koch, JGP Tijssen, JPS Henriques. Adjunctive Thrombus Aspiration versus Conventional Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction. Catheterization and Cardiovascular Interventions, 2013 81(6):922-9 (IF 2.5)

2012

22. R Jarai, GD Dangas, K Huber, BEPM Claessen, R Mehran, GW Stone. B-Type Natriuretic Peptide and the Risk of Contrast Induced Nephropathy in Acute ST-Elevation Myocardial Infarction: Analysis from the HORIZONS-AMI Trial. Circulation Cardiovascular Interventions, 2012;5(6):200-8 (IF 6.5)

23. J YU, R Mehran, GD Dangas, BEPM Claessen, K XU, H Parise, M Fahy, AJ Lansky, B Witzenbichler, CL Grines, G Guagliumi, R Kornowski, D Dudek, J Wohrle, G Weisz, GW Stone. Is High Dose Aspirin Effective After Acute Myocardial Infarction? 3-Year Results from the HORIZONS-AMI Trial. JACC cardiovascular Interventions, 2012;5(12):1231-8 (IF 6.6)

24. GD Dangas, BEPM Claessen, R Mehran, K Xu, M Fahy, H Parise, JPS Henriques, EM Ohman, HD White, GW Stone. Development and Validation of a Stent Thrombosis Risk Score in Patients with Acute Coronary Syndromes. JACC Cardiovascular Interventions, 2012;5(11):1097-105 (IF 6.6)

25. BEPM Claessen, A Chieffo, GD Dangas, C Godino, SW Lee, K Obunai, M Carlino, V Chantziara, I Apostolidou, JPS Henriques, MB Leon, C DiMario, SJ Park, GW Stone, JW Moses, A Colombo, R Mehran, on behalf of the Multinational CTO Registry. Gender Differences in Long-Term Clinical Outcomes after Percutaneous Coronary Intervention of Chronic Total Occlusions. Journal of Invasive Cardiology, 2012;24(10): 484-488 (IF 1.6)

26. GD Dangas, BEPM Claessen, R Mehran, B Brodie, Dariusz Dudek, B Witzenbichler, JZ Peruga, G Guagliumi, JW Moses, K Xu, GW Stone. Clinical Outcomes Following Stent Thrombosis Occurring In-Hospital versus Out-of-Hospital: results from the HORIZONS-AMI Trial. Journal of the American College of Cardiology, 2012;15(20):1752-9 (IF 14.1)

27. BEPM Claessen, GW Stone, R Mehran, B Witzenbichler, BR Brodie, J Wöhrle, A Witkowski, G Guagliumi, K Zmudka, JPS Henriques, JGP Tijssen, EA Sanidas, V Chantziara, D Hakim, S Leon, Ke Xu, GD Dangas. Relationship between Biomarkers and Subsequent Clinical and Angiographic Restenosis after Paclitaxel-Eluting Stents for Treatment of ST-Segment Elevation Myocardial Infarction: A HORIZONS-AMI Substudy. Journal of Thrombosis and Thrombolysis, 2012;34(2): 165-79 (IF 2.0)

28. BEPM Claessen, R Mehran, GW Stone. Everolimus-Eluting Stents in Real World Practice. Editorial, Revista Brasileira de Hemodynamica e Cardiologia Intervencionista, 2011;19(4):351-2 (no IF)

29. BEPM Claessen, A Maehara, M Fahy, K Xu, GW Stone, GS Mintz. Plaque Composition by Virtual Histology Intravascular Ultrasound and Distal Embolization after Percutaneous Coronary Intervention: A Systematic Review. JACC cardiovascular imaging, 2012;5 (3 suppl):S111-8 (IF 6.2)

30. BEPM Claessen, GD Dangas, G Weisz, B Witzenbichler, G Guagliumi, M Möckel, K Xu, JPS Henriques, R Mehran, GW Stone. Prognostic Impact of a Chronic Total Occlusion in a Non-Infarct Related artery in Patients with ST-segment Elevation Myocardial Infarction: Three-Year results from the HORIZONS-AMI Trial. European Heart Journal, 2012;33(6):768-75 (IF 14.1)

31. BEPM Claessen, GD Dangas, R Mehran. Reply. JACC Cardiovascular Interventions, 2012;5(1):117-8 (IF 6.6)

32. LP Hoebers, P Damman, BEPM Claessen, WJ Kikkert, AE Engstrom, MM Vis, J Baan Jr, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Predictive Value of Plasma Glucose Level on Admission for Short- and Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention. American Journal of Cardiology, 2012;109(1):53-9 (IF 3.2)

33. GJ Vlachojannis, BEPM Claessen, GD Dangas. Early Stent Thrombosis after primary PCI in STEMI. Interventional Cardiology, 2012;7(1):33-36 (no IF)

2011

34. K Goto, E Nikolsky, AJ Lansky, GD Dangas, B Witzenbichler, H Parise, G Gaugliumi, R Kornowski, BEPM Claessen, M Fahy, R Mehran, GW Stone. Impact of Smoking on Outcomes of Patients with ST-segment Elevation Myocardial Infarction: A Subanalysis from HORIZONS-AMI. American Journal of Cardiology, 2011;108(10):1387-94 (IF 3.2)

35. BEPM Claessen, R Mehran, GS Mintz, G Weisz, MB Leon, O Dogan, GW Stone, I Apostolidou, A Morales, V Chantziara, G Syros, E Sanidas, K Xu, JGP Tijssen, JPS Henriques, JW Moses, A Maehara, GD Dangas. Impact of Intravascular Ultrasound Imaging on Early and Late Clinical Outcome Following Percutaneous Coronary Intervention with Drug-Eluting Stents. JACC Cardiovascular Interventions 2011;4(9):974-81 (IF 6.6)

36. BEPM Claessen, PC Smits, DJ Kereiakes, H Parise, M Fahy, E Kedhi, PW Serruys, K Sudhir, P Sood, CA Simonton, GW Stone. Impact of Lesion Length and Vessel Size on Clinical Outcomes after Percutaneous Coronary Intervention with Everolimus-Eluting vs. Paclitaxel-Eluting Stents: Pooled Analysis from the SPIRIT and COMPARE Randomized Trials. JACC Cardiovascular Interventions, 2011;4(11):1209-15 (IF 6.6)

37. JW Suh, R Mehran, BEPM Claessen, K Xu, U Baber, GD Dangas, H Parise, AJ Lansky, B Witzenbichler, CL Grines, G Guagliumi, R Kornowski, J Wohrle, D Dudek, G Weisz, GW Stone. Impact of Major Bleeding on Long term Care and Outcomes of Patients after Primary Angioplasty: Three Year Results of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Journal of the American College of Cardiology, 2011;58(17):1750-6 (IF 14.1)

38. AJ Saltzman, GW Stone, BEPM Claessen, A Narula, G Weisz, B Brodie, B Witzenbichler, G Guagliumi, R Kornowski, D Dudek, DC Metzger, AJ Lansky, E Nikolsky, GD Dangas. Long-Term Impact of Chronic Kidney Disease in Patients with STEMI Treated with Primary Percutaneous Coronary Intervention: The HORIZONS-AMI Trial. JACC Cardiovascular Interventions, 2011;4(9):1011-9 (IF 6.6)

39. BEPM Claessen, GD Dangas, C Godino, SW Lee, K Obunai, JW Suh, MB Leon, C DiMario, SJ Park, GW Stone, JW Moses, A Colombo, R Mehran, on behalf of the multinational CTO registry. Long-Term Clinical Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusions in Patients with versus without Diabetes Mellitus. American Journal of Cardiology, 2011;108(7):924-31 (IF 3.2)

40. BEPM Claessen, GD Dangas. Thrombus Aspiration in Primary Percutaneous Coronary Intervention: How to Manage Failure. Editorial comment, JACC Cardiovascular Interventions, 2011;4(6):643-4 (IF 6.6)

41. BEPM Claessen, R Mehran, MB Leon, EA Heller, G Weisz, G Syros, GS Mintz, T Franklin-Bond, I Apostolidou, JPS Henriques, GW Stone, JW Moses, GD Dangas. Two-Year Safety and Effectiveness of Sirolimus-Eluting Stents (From a Prospective Registry) American Journal of Cardiology, 2011;107(4):528-34 (IF 3.2)

42. R Mehran*, BEPM Claessen*, C Godino, GD Dangas, K Obunai, S Kanwal, M Carlino, JPS Henriques, C Di Mario, YH Kim, SJ Park, GW Stone, MB Leon, JW Moses and A Colombo, on behalf of the multinational CTO registry. Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusions. JACC Cardiovascular Interventions, 2011;4(9):952-61 *Both authors contributed equally (IF 6.6)

43. R Kornowski, R Mehran, GD Dangas, E Nikolsky, A Assali, BEPM Claessen, BJ Gersch, C Wong, B Witzenbichler, G Guagliumi, D Dudek, M Fahy, AJ Lansky, GW Stone, for the HORIZONS-AMI Trial Investigators. Prognostic Impact of Staged versus “one-time” Multivessel Percutaneous Intervention in Acute Myocardial Infarcion: Analysis from the HORIZONS-AMI Trial. Journal of the American College of Cardiology, 2011;58(7):704-11 (IF 14.1)

44. DA Hakim, GD Dangas, A Caixeta, E Nikolsky, AJ Lansky, JW Moses, BEPM Claessen, E Sanidas, HD White, EM Ohman, SV Manoukian, M Fahy, R Mehran, GW Stone. Impact of Baseline Thrombocytopenia on the Early and Late Outcomes after ST-Elevation Myocardial Infarction Treated with Primary Angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. American Heart Journal, 2011;161(2):391-6 (IF 4.5)

45. GD Dangas, R Mehran, E Nikolsky, BEPM Claessen, AJ lansky, BR Brodie, B Witzenbichler, G Guagliumi, JZ Peruga, D Dudek, M Moëckel, A Caixeta, H Parise, HD White, GW Stone, for the HORIZONS-AMI Trial Investigators. Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial. Journal of the American College of Cardiology, 2011;57(23):2309-16 (IF 14.1)

46. R Mehran, S Pocock, E Nikolsky, GD Dangas, T Clayton, BEPM Claessen, A Caixeta, F Feit, S Manoukian, HD White, M Bertrand, M Ohman, H Parise, AJ Lansky, AM Lincoff, GW Stone. Impact of Bleeding Types on Mortality After PCI: Results from a patient-level pooled analysis of the REPLACE-2, ACUITY and HORIZONS trials. JACC Cardiovascular Interventions, 2011;4(6):654-64 (IF 6.6)

47. AE Engstrom, KD Sjauw, J Baan Jr, M Remmelink, BEPM Claessen, WJ Kikkert, LPC Hoebers, MM Vis, KT Koch, M Meuwissen, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Long-Term Safety and Sustained Left Ventricular Recovery: Long-Term Results of Percutaneous Left Ventricular Support with Impella LP2.5 in ST-Elevation Myocardial Infarction. EuroIntervention, 2011;6(7):860-5 (IF 3.2)

48. EA Sanidas, A Maehara, GS Mintz, T Kashiyama, J Guo, BEPM Claessen, GD Dangas, MB Leon, JW Moses, GW Stone, Y Ueda. An Angioscopic and Virtual Histology Intravascular Ultrasound Study of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis. American Journal of Cardiology 2011;107(9):1285-90 (IF 3.2)

2010

49. BEPM Claessen, JPS Henriques, GD Dangas. Clinical Studies with Sirolimus, Zotarolimus, Everolimus, and Biolimus A9 Drug-Eluting Stent Systems. Review, Current Pharmaceutical Design, 2010;16(36):4012-24 (IF 3.3)

50. G Dangas, BEPM Claessen, A Caixeta, E Sanidas, GS Mintz, R Mehran. In-Stent Restenosis in the Drug-Eluting Stent Era. Review, Journal of the American College of Cardiology, 2010;56(23):1897-907 (IF 14.1)

51. BEPM Claessen, A Caixeta, JPS Henriques, JJ Piek. Current status of the XIENCE Vtm everolimus-eluting coronary stent system. Review, Expert Review of Cardiovascular Therapy 2010;8(10):1363-1374 (no IF)

52. BEPM Claessen, R Mehran, GW Stone, Evaluating the need for a practical risk score to predict major bleeding in acute coronary syndromes. Editorial, Interventional Cardiology 2010;2(6):757-759 (no IF)

53. MA Beijk, BEPM Claessen, KT Koch; JPS Henriques; RJ Van der Schaaf, J Baan Jr., MM Vis, M Meesterman, JGP Tijssen, JJ Piek, RJ De Winter. One-year Clinical Outcome After Treatment of Bare-Metal Stent In-Stent Restenosis with the Paclitaxel-Eluting Stent in an Unselected Cohort. International Journal of Cardiology 2010;145(3):608-9 (IF 5.5)

54. RJ van der Schaaf*, BEPM Claessen*, LPC Hoebers*, NJ Verouden, JJ Koolen, MJ Suttorp, E Barbato, M Bax, BH Strauss, GK Olivecrona, V Tuseth, D Glogar, T Ramunddal, JGP Tijssen, JJ Piek, JPS Henriques. Rationale and Design of EXPLORE: a Ranzomied, Prospective, Multicenter Trial Investigating the Impact of Recanalization of a Chronic Total Occlusion on Left Ventricular Function in Patients after Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction. Trials 2010;11:89 *first three authors contributed equally to the manuscript (IF 2.2)

55. BEPM Claessen*, LPC Hoebers*, WJ Kikkert, AE Engstrom, KT Koch, MM Vis, J Baan Jr., MM Meuwissen, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of a Chronic Total Occlusion in a Non-Infarct Related Artery on Long-Term Mortality in Patients With Diabetes Mellitus After ST Elevation Myocardial Infarction. Heart 2010;96(24):1968-1972 both authors contributed equally (IF 5.0)

56. BEPM Claessen, JPS Henriques, JC George, G Dangas. SCAI 2010 and EuroPCR 2010: Update in Interventional Cardiology. News and Views, JACC cardiovascular interventions 2010;3(8):882-884 (IF 6.6)

57. BEPM Claessen, WJ Kikkert, RJ van der Schaaf, AE Engstrom, MM Vis, J Baan Jr., KT Koch, M Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in Octogenarians; Trends and Outcomes From an Eleven-Year Single Center Experience. Heart 2010;96(11):854-859 (IF 5.0)

58. RJ van der Schaaf, BEPM Claessen, MM Vis, KT Koch, J Baan, M Meuwissen, AE Engstrom, WJ Kikkert, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of multivessel disease with or without a concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock. American Journal of Cardiology 2010;105(7):955-959 (IF 3.2)

59. LPC Hoebers, BEPM Claessen, RJ van der Schaaf, JPS Henriques. Relation of Multivessel Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction to Outcome and/or Non-Infarct Artery Intervention of a Chronic total Occlusion. Letter to the editor, American Journal of Cardiology 2010;105(6):902-903 (IF 3.2)

60. BEPM Claessen, M Bax, R Delewi, M Meuwissen, JPS Henriques, JJ Piek. The Doppler flow-wire in acute myocardial infarction. Review, Heart 2010;96(8):631-635 (IF 5.0)

61. BEPM Claessen, GW Stone, PC Smits, E Kedhi, WJ Kikkert, JJ Piek, JPS Henriques. Would SYNTAX have been a positive trial if XIENCE V was used instead of TAXUS? A meta-analysis of a first vs. a next generation drug eluting stent Netherlands Heart Journal 2010;18(9):451-453 (IF 1.4)

62. AE Engström, MM Vis, BJ Bouma, RBA van den Brink, RJ van der Schaaf. KD Sjauw, BEPM Claessen, KT Koch, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Right ventricular dysfunction is an independent predictor for long term mortality in ST-elevation myocardial infarction patients presenting with cardiogenic shock on admission. European Journal of Heart Failure 2010;12(3):780-787 (IF 5.2)

63. AE Engström, MM Vis, BJ Bouma, BEPM Claessen, KD Sjauw, J Baan Jr., KT Koch, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Mitral regurgitation is an independent predictor of 1-year mortality in ST-elevation myocardial infarction patients presenting in cardiogenic shock on admission. Acute Cardiac Care 2010 Jun;12(2):51-57 (no IF)

2009

64. BEPM Claessen, MA Beijk, V Legrand, W Ruzyllo, A Manari, C Spaulding, MJ Suttorp, JGP Tijssen, K Miquel-Hebert, S Veldhof, JPS Henriques, PW Serruys, JJ Piek. Two Year Clinical, Angiographic and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With de novo Native Coronary Artery Lesions: The SPIRIT II Trial Circulation Cardiovascular Interventions 2009;2(4):339-347 (IF 6.5)

65. BEPM Claessen, RJ van der Schaaf, CJ Verouden, NK Stegenga, AE Engstrom, KD Sjauw, WJ Kikkert, MM Vis, KT Koch, J Baan Jr., JG Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Evaluation of the Effect of a Concurrent Chronic Total Occlusion on Mortality and Left Ventricular Function After Primary Percutaneous Coronary Intervention. JACC Cardiovascular Interventions 2009;2(11):1128-1134 (IF 6.6)

2008

66. MGH van Oijen, BEPM Claessen, N Clappers, A van Schaik, RJF Laheij, JBMJ Jansen, WHM Peters and FWA Verheugt. Prognostic Value of Free Plasma Homocysteine Levels in Patients Hospitalized with Acute Coronary Syndrome. American Journal of Cardiology 2008;102(2): 135-139 (IF 3.2)

Submitted papers

L Mehta, R Mehran, A Chieffo, AP Kappetein, R Virmani, WS Weintraub, BEPM Claessen, I Narbute, A Erglis, K O’Callaghan, N Hanafi, SJ Head, RL Osnabrugge, CN Hess, M Nakano, G Stefanini, U Baber, D Itchaporia. Stable Ischemic Heart Disease: Why Women Matter in Clinical Trials. Submitted

LP Hoebers, BE Claessen, GD Dangas, R Mehran, JPS Henriques. Meta-analysis on the Impact of Percutaneous Coronary Intervention of Chronic Total Occlusions on Left Ventricular Function and Clinical Outcome. Submitted

BEPM Claessen, WJ Kikkert, LP Hoebers, H Bahadurzada, M Vis, J Baan Jr., KT Koch, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Long-Term Ischemic and Bleeding Outcomes after Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction in Patients aged <60 years, 60-79 years, and ≥80 years. Submitted

EP Navarese, M Kowalewski, F Andreotti, M Kolodziejczak, V Schulze, S Dias, BEPM Claessen, M Brouwer, G Tarantini, S Iliceto, J Eikelboom, GYH Lip, M Valgimigli, M Kelm, S Berti. Comparative Efficacy and Safety of Anticoagulation Strategies for Acute Coronary Syndromes. Comprehensive Network Meta-analysis of 42 Randomised Trials involving 117,353 patients. Submitted

JJ Piek, BEPM Claessen, J Davies, J Escaned. Myocardial revascularization revisited. Submitted

WJ Kikkert, PM van Brussel, P Damman, BEPM Claessen, JP van Straalen, MM Vis, KT Koch, RJ Peters, RJ de Winter, JJ Piek, JGP Tijssen, JPS Henriques. Influence of Chronic Kidney Disease on Anticoagulation Levels and Bleeding after Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in Patients Treated with Unfractionated Heparin. Submitted

Book Chapters

1. BEPM Claessen, M Bax, JJ Piek. Doppler flow-wire. In: G De Luca and A Lansky, editors: Mechanical Reperfusion For STEMI: From Randomized Trials to Clinical Practice. Informa Healthcare, 2010. ISBN: 9781841846965

2. BEPM Claessen, R Mehran, GD Dangas. In-Stent Restenosis. In: CathSAP4, online self-assessment course for interventional cardiologists. Published by the American College of Cardiology at www.cardiosource.org.

3. BEPM Claessen, ES Brilakis, U Baber, JPS Henriques, R Mehran, GD Dangas. Rationale and Technique for Percutaneous Coronary Intervention of Chronic Total Occlusions. In: P Lanzer and E Topol, editors: Panvascular II, 2014. ISBN: tbd

Invited Oral Presentations

1. 2nd SCAI women in Innovations and American College of Cardiology Gender Data Forum. Results from the CTO Multi-Center Registry. September 24th, 2012

2. 62nd ACC scientific sessions. Predicting Distal Embolization Using Grayscale IVUS, VH-IVUS, IB-IVUS, OCT, NIRS and CTA. March 9th, 2013

Oral Abstract Presentations

1. BEPM Claessen, MGH van Oijen, N Clappers, A van Schaik, RJF Laheij, JBMJ Jansen, WHM Peters, FWA Verheugt. Prognostic value of free versus total plasma homocysteine in patients hospitalized with acute coronary syndromes. Netherlands Heart Journal, 2008, volume 16, supplement 1. Presented at Dutch society of cardiology, Amsterdam, april 17th 2008

2. BEPM Claessen, RJ Van der Schaaf, NJ Verouden, KT Koch, MM Vis, J Baan, JG Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of a concurrent chronic total occlusion on residual left ventricular ejection fraction in patients after primary percutaneous coronary intervention. Netherlands Heart Journal, 2008, volume 16, supplement 2. Presented at Dutch society of cardiology, Amsterdam, October 2nd 2008

3. BEPM Claessen, RJ Van der Schaaf, KT Koch, MM Vis, J Baan, JG Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of a concurrent chronic total occlusion on long-term mortality in hospital survivors after ST-elevation myocardial infarction. American Journal of Cardiology, volume 102, supplement 1, page 35i. Presented at TCT, Washington, October 15th 2008

4. BEPM Claessen, RJ van der Schaaf, KT Koch, MM Vis, J Baan Jr., MM Meuwissen, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of a Chronic Total Occlusion in a Non-Infarct Related Artery on Long-Term Mortality in Patients With Diabetes Mellitus After ST Elevation Myocardial Infarction. Circulation, volume 120, pages s983-s984. Presented at AHA, Orlando, November 18th 2009

5. BEPM Claessen, GS Mintz, R Mehran, A Maehara, G Weisz, E Sanidas, G Syros, T Franklin-Bond, I Apostolidou, JPS Henriques, GW Stone, JW Moses, MB Leon, GD Dangas. Intravascular Ultrasound-Guided Drug-Eluting Stent Placement is Associated with Reduced Incidence of Recurrent Clinical Events (Death or MI). Journal of the American College of Cardiology, supplement 1, 2010, 56(13):B10. Presented at TCT, Washington, September 22nd 2010

6. BEPM Claessen, R Mehran, C Godino, K Obunai, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, MB Leon, JW Moses, on behalf of the Multinational CTO Registry. Long-Term Clinical Outcomes after Percutaneous Coronary Intervention with Drug-eluting Stents versus Bare Metal Stents for Chronic Total Occlusions: Two-Year Outcomes from a 1,791 Patient Multi-National Registry. Journal of the American College of Cardiology, supplement 1, 2010, 56(13):B7. Presented at TCT, Washington, September 22nd 2010

7. BEPM Claessen, R Mehran, K Obunai, C Godino, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, JW Moses, MB Leon, on behalf of the Multinational CTO Registry. Impact of Target Vessel on Long-Term Survival after Percutaneous Coronary Intervention for Chronic Total Occlusions: Two-Year Outcomes from a 1,791 Patient Multi-National Registry. Journal of the American College of Cardiology, supplement 1, 2010, 56(13):B7-8. Presented at TCT, Washington, September 22nd 2010

8. BEPM Claessen, R Mehran, C Godino, K Obunai, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, MB Leon, JW Moses, on behalf of the Multinational CTO Registry. Impact of Successful Percutaneous Coronary Intervention of a Chronic Total Occlusion: Five-Year Outcomes from a 1,791 Patient Multinational Registry. Circulation, supplement, November 2010, 122:A19992. Presented at AHA, Chicago, November 16th, 2010

9. BEPM Claessen, R Mehran, C Godino, K Obunai, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, MB Leon, JW Moses, on behalf of the Multinational CTO Registry. Temporal Trends in Percutaneous Coronary Intervention for Chronic Total Occlusions: a Report from the 1,791 Patient Multinational CTO Registry. Circulation, supplement, November 2010, 122:A20246. Presented at AHA, Chicago, November 16th, 2010

10. BEPM Claessen, R Mehran, C Godino, K Obunai, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, MB Leon, JW Moses, on behalf of the Multinational CTO Registry. Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Patients with and without Diabetes Mellitus: Five-Year Outcomes from a 1,791 Patient Multi-National Registry. JACC supplement, 2011, in print. Presented at ACC, New Orleans, April 3rd, 2011

11. BEPM Claessen, GD Dangas, R Mehran, B Witzenbichler, G Guagliumi, JZ Peruga, K Xu, GW Stone. Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital; results of the HORIZONS-AMI trial. Presented at ESC, Paris, august 30th, 2011

12. BEPM Claessen, R Mehran, C Godino, K Obunai, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, MB Leon, JW Moses, on behalf of the Multinational CTO Registry. Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Insulin and Non-Insulin Dependent Diabetes Mellitus: Five-Year Outcomes from a 1,791 Patient Multi-National Registry. Presented at TCT , San Francisco, November 8th, 2011

13. BEPM Claessen, GD Dangas, R Mehran, B Witzenbichler, G Guagliumi, JZ Peruga, HD White, K Xu, GW Stone. Clinical outcomes after Acute, Subacute, Late, and very Late Stent Thrombosis: An Analysis from HORIZONS-AMI. Presented at TCT , San Francisco, November 8th, 2011

14. BEPM Claessen, GD Dangas, R Mehran, K XU, M Fahy, H Parise, EM Ohman, HD White, GW Stone. Development and Validation of a Stent Thrombosis Risk Score in Patients with Acute Coronary Syndromes. Presented at AHA, Orlando, November 14th, 2011

15. BEPM Claessen, G Syros, R Mehran, E Sanidas, V Chantziara, I Apostolidou, G Weisz, L Rabbani, C Hooper, GD Dangas. MKL1 C-184>T and CYP3A5 A-6986>G Polymorphisms Are Associated with Contrast Induced Acute Kidney Injury after PCI. Presented at ACC, San Francisco, March 9th, 2013

16. BEPM Claessen, WJ kikkert, LP Hoebers, MM Vis, J Baan, K Koch, RJ de Winter, JJ Piek, JPS Henriques. Long-Term Ischemic and Bleeding Outcomes after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction in the Very Elderly (80+). Presented at ESC, Barcelona, september 2nd 2014

Co-Authored Abstracts Selected for Oral Presentation

1. NJ Verouden, BEPM Claessen, RJ van der Schaaf, KT Koch, J Baan, MM Vis, JGP Tijssen, JJ Piek, JPS Henriques, RJ de Winter. Incomplete ST-Segment Deviation Resolution after Primary Percutaneous Coronary Intervention in Patients with Multivessel Disease is Mainly Due to the Presence of a Non-Infarct-Related Chronic Total Occlusion. Oral Presentation, presented at AHA, New Orleans, November 12th 2008

2. LP Hoebers, WJ Kikkert, P Damman, BEPM Claessen, Vis MM, J Baan, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Predictive value of plasma glucose level at admission for short and long term mortality in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Oral Presentation, presented at ESC, Stockholm, September 2nd, 2010

3. Mehran R, BEPM Claessen, C Godino, K Obunai, GD Dangas, M Carlino, YH Kim, C DiMario, SJ Park, GW Stone, A Colombo, JW Moses, MB Leon, on behalf of the Multinational CTO Registry. Long-Term Clinical Safety and Efficacy of Drug-Eluting Stents for the Treatment of Chronic Total Occlusions: Report from a Multi-National 763 Patient Registry. Oral Presentation, presented at TCT, Washington, September 22nd, 2010

4. WJ Kikkert, N van Geloven, BEPM Claessen, MM Vis, J Baan, K Koch, RJ de Winter, JJ Piek, JPS Henriques. Increased 1-Year Survival After Adjunctive Thrombus Aspiration for ST-Elevation Myocardial Infarction Patient. Oral Presentation, presented at TCT, Washington, September 22nd, 2010

5. LP Hoebers, BEPM Claessen, WJ Kikkert, AE Engstrom, MM Vis, KT Koch, J Baan, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of Multivessel Disease with and without a Concurrent Chronic Total Occlusion on Short and Long-Term Mortality in ST-Elevation Myocardial Infarction Patients with and without Cardiogenic Shock. Oral Presentation, presented at ACC, New Orleans, April 3rd, 2011

6. JC Kovacic, R Mehran, GD Dangas, BEPM Claessen, H Parise, M Fahy, AJ Lansky, B Witzenbichler, CL Grines, G Guagliumi, R Kornowski, J Wöhrle, D Dudek, G Weisz, GW Stone. Impact of Aspirin Dose on Long Term Clinical Outcomes after Stenting for Acute Myocardial Infarction: 3-Year Follow-Up Data from the HORIZONS-AMI Trial. Oral Presentation, presented at ACC, New Orleans, April 3rd, 2011

7. AJ Saltzman, BEPM Claessen, A Narula, G Weisz, B Brodie, B Witzenbichler, G Guagliumi, R Kornowski, D Dudek, AJ Lansky, E Nikolsky, GD Dangas, GW Stone, R Mehran. Impact of Chronic Kidney Disease on Long-Term Outcomes in ST-Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Interventions and Alternative Antithrombotic Treatment Strategies: A HORIZONS-AMI Substudy. Oral Presentation, presented at ACC, New Orleans, April 4th, 2011

8. LP Hoebers, BEPM Claessen, WJ Kikkert, MM Vis, KT Koch, J Baan, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques.The Impact of the Location of a Chronic Total Occlusion in a non-Infarct Related Artery on Long-Term Mortality in ST-Elevation Myocardial Infarction Patients. Oral presentation, presented at TCT, San Francisco, November 8th, 2011

Moderated Poster Abstract Presentations

1. BEPM Claessen, RJ Van der Schaaf, KT Koch, MM Vis, J Baan, JG Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of a Concurrent Chronic Total Occlusion on Long-term Mortality in Hospital Survivors after ST Elevation Myocardial Infarction. Circulation, volume 113, supplement page S_967. Moderated poster, presented at AHA, New Orleans, November 12th 2008

2. BEPM Claessen, AE Engstrom, WJ Kikkert, MM Vis, KT Koch, J Baan Jr., MM Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Primary Percutaneous Intervention for ST Elevation Myocardial Infarction in Octogenarians; Trends and Outcomes from a nine-year single center experience. Moderated poster, presented at ESC, Barcelona, August 31st 2009

Poster and E-Poster Abstract presentations

1. BEPM Claessen, RJ van der Schaaf, CJ Verouden, MM Vis, KT Koch, J Baan Jr, JG Tijssen, RJ de Winter, JJ Piek, JP Henriques. Impact of a concurrent chronic total occlusion on recovery of left ventricular ejection fraction in patients with multivessel disease after primary percutaneous coronary intervention. European Heart Journal, volume 29, supplement 1, September 2008, page 72. Poster, Presented at ESC, Munich August 31st 2008

2. MGH van Oijen, BEPM Claessen, N Clappers, A van Schaik, RJF Laheij, JBMJ Jansen, WHM Peters, FWA Verheugt. Prognostic value of free versus total plasma homocysteine in patients hospitalised with acute coronary syndromes. European Heart Journal, volume 29, supplement 1, September 2008, page 592-593. Poster, Presented at ESC, Munich, September 2nd 2008

3. RJ Van der Schaaf, NJ Verouden, BEPM Claessen, KT Koch, MM Vis, J Baan, JG Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for ST-elevation myocardial infarction: rationale and design of the EXPLORE trial. American Journal of Cardiology, volume 102, supplement 1, page 110i. E-poster, presented at TCT, October 12-17 2008

4. NJ Verouden, BEPM Claessen, RJ van der Schaaf, KT Koch, J Baan, MM Vis, JG Tijssen, JJ Piek, JPS Henriques, RJ de Winter. Incomplete ST-segment deviation resolution after primary percutaneous coronary intervention in patients with multivessel disease is mainly due to the presence of a non-infarct related chronic total occlusion. American Journal of Cardiology, volume 102, supplement 1, page 71i-72i. E-poster, presented at TCT, October 12-17 2008

5. BEPM Claessen, RJ van der Schaaf, NJ Verouden, NK Stegenga, AE Engstrom, KD Sjauw, MM Vis, KT Koch, JG Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Evaluation of the Effect of a Concurrent Chronic Total Occlusion on Long Term Mortality and Left Ventricular Function in patients after Primary Percutaneous Coronary Intervention. Poster, presented at BWGIC-WIC annual scientific joint meeting, Amsterdam, December 13th 2008

6. BEPM Claessen, RJ Van der Schaaf, KT Koch, MM Vis, J Baan, JG Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of 2-vessel disease, 3-vessel disease and a Chronic Total Occlusion in a non-infarct related artery on Long-term Mortality after STEMI. Journal of the American College of Cardiology, volume 53, page A336, supplement 1 Poster, presented at ACC, Orlando, March 30th 2009

7. BEPM Claessen, AE Engstrom, WJ Kikkert, RJ van der Schaaf, MM Vis, J Baan, MM Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in Octogenarians: Trends and Outcomes from a Nine-Year Single Center Experience. Netherlands Heart Journal, volume 17, supplement 1. Poster, Presented at Dutch society of cardiology, Amsterdam, April 3rd 2009

8. NJ Verouden, JD Haeck, BEPM Claessen, KT Koch, JPS Henriques, J Baan Jr., MM Vis, JJ Piek, JGP Tijssen, RJ de Winter. Expanding the smoker’s paradox: Smoking is associated with significantly better ST-segment recovery and survival in patients with acute myocardial infarction undergoing primary angioplasty. American Journal of Cardiology, volume 104, supplement, page 119D-120D. Poster, presented at TCT, San Francisco, September 22nd 2009

9. BEPM Claessen, RJ van der Schaaf, KT Koch, MM Vis, J Baan Jr., MM Meuwissen, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques. Impact of a Chronic Total Occlusion in a Non-Infarct Related Artery on Long-Term Mortality in Patients With Diabetes Mellitus After ST Elevation Myocardial Infarction. American Journal of Cardiology, volume 104, supplement, page 90D. Poster, presented at TCT, San Francisco, September 22nd 2009

10. BEPM Claessen, AE Engstrom, WJ Kikkert, MM Vis, KT Koch, J Baan Jr., MM Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction In Octogenarians. Trends and Outcomes From a Ten-Year Single Center Experience. American Journal of Cardiology, volume 104, supplement, page 117D. Poster, presented at TCT, San Francisco, September 22nd 2009

11. WJ Kikkert, BEPM Claessen, AE Engstrom, M Meuwissen, M Vis, J Baan, RJ de Winter, KT Koch, JJ Piek, JPS Henriques. Early Activated Partial Thromboplastin Time is a Predictor of 30-day and 1-year Mortality in ST Elevation Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention and Unfractionated Heparin. Circulation, volume 120, page s939. Poster, presented at AHA, Orlando, November 16th, 2009

12. BEPM Claessen, RJ van der Schaaf, MM Vis, KT Koch, J Baan Jr., MM Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Multivessel Primary Percutaneous Coronary Intervention in Patients with Multivessel Disease and ST-Elevation Myocardial Infarction Complicated with Cardiogenic Shock. Circulation, volume 120, page s924 Poster, presented at AHA, Orlando, November 15th 2009

13. WJ Kikkert, BEPM Claessen, AE engstrom, MM Vis, J Baan Jr., M Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Relationship between renal function, anticoagulation levels and clinical outcome in ST-elevation myocardial infacrtion patients treated with primary percutaneous coronary intervention and unfractionated heparin. Journal of the American college of cardiology, volume 55, supplement 1, page A102. Poster, presented at ACC10/I2 ‘10 Atlanta, march 15th 2010

14. LPC Hoebers, BEPM Claessen, MM vis, KT Koch, J Baan Jr., M Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Long-Term Mortality in Insulin Dependent Versus Non-Insulin Dependent Diabetic ST Elevation Myocardial Infarction Patients after Primary Percutaneous Coronary Intervention. Journal of the American college of cardiology, volume 55, supplement 1, page A210 Poster, presented at ACC10/I2 ‘10 Atlanta, march 15th 2010

15. BEPM Claessen, WJ Kikkert, MM vis, KT Koch, J Baan Jr., M Meuwissen, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Age and One-Year Mortality After ST Elevation Myocardial Infarction Treated With Primary Percutaneous Intervention. Journal of the American college of cardiology, volume 55, supplement 1, page A187 . Poster, presented at ACC10/I2 ‘10 Atlanta, march 14th 2010

16. AE Engstrom, KD Sjauw, J Baan, M Remmelijk, BEPM Claessen, WJ Kikkert, LPC Hoebers, JJ Piek, JPS Henriques. Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction. Poster, presented at ESC, Stockholm, 2010

17. WJ Kikkert, BEPM Claessen, AE Engstrom, MM Vis, J Baan, KT Koch, RJ de Winter, JGP Tijssen, JJ Piek, JPS Henriques. Influence of chronic kidney disease on outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Poster, presented at ESC, Stockholm, 2010

18. BEPM Claessen, GW Stone, PC Smits, E Kedhi, WJ Kikkert, JJ Piek, JPS Henriques. Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents: A Meta-Analysis of 4 Trials. Journal of the American College of Cardiology, supplement 1, 2010, 56(13):B63-4. Poster, presented at TCT, Washington, September 22nd 2010

19. A Caixeta, R Mehran, G Dangas, B Witzenbicher, G Guagliumi, JZ Peruga, B Brodie, D Dudek, F Hartmann, BEPM Claessen, S Leon, AJ lansky, GW Stone. Clinical Outcomes in Patients with Right Coronary vs. Left Circumflex Artery Myocardial Infarction Treated With Primary PCI: Results of the HORIZONS-AMI Trial. Journal of the American College of Cardiology, supplement 1, 2010, 56(13):B100. Poster, presented at TCT, Washington, September 22nd 2010

20. WJ Kikkert, N van Geloven, BEPM Claessen , MM Vis, J Baan, KT Koch, RJ de Winter, JJ Piek, JPS Henriques. Thrombus Aspiration During Revascularization for Acute Myocardial Infarction Improves 1-year Survival in a Large Propensity Matched Cohort. Poster, presented at AHA, Chicago, November 15th 2010

21. BEPM Claessen, R Mehran, K Obunai, C Godino, A Chieffo, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, JW Moses, MB Leon, on behalf of the Multinational CTO Registry. Gender Differences in Percutaneous Coronary Intervention for Chronic Total Occlusions: a Report from the 1,781 Patient Multinational CTO Registry. Circulation, supplement, November 2010, 122:A20362. Poster, presented at AHA, Chicago, November 16th 2010

22. B Witzenbichler, GW Stone, BEPM Claessen, BR Brodie, W Ruzyllo, K Zmudka, G Guagliumi, J Wohrle, K Huber, J Kochman, F Hartmann, I Apostolidou, G Syros, S Leon, R Mehran, GD Dangas. Relationship Between Biomarkers and Subsequent Major Cardiovascular Events after ST-Elevation Myocardial Infarction: A HORIZONS-AMI Substudy. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 4th, 2011

23. JW Suh, R Mehran, BEPM Claessen, GD Dangas, H Parise, AJ Lansky, B Witzenbichler, CL Grines, G Guagliumi, R Kornowski, J Wohrle, D Dudek, G Weisz, JW Moses, GW Stone. Discharge Medication Use in Patients who Experience Bleeding Complications after Primary PCI: Analysis from Horizons-AMI. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 4th, 2011

24. BEPM Claessen, GW Stone, R Mehran, B Witzenbichler, B Brody, W Ruzyllo, K Zmudka, G Guagliumi, J Wohrle, K Huber, J Kochman, F Hartmann, E Sanidas, D Hakim, V Chantziara, S leon, GD Dangas. Relationship between Biomarkers and Subsequent Clinical and Angiographic Restenosis after Paclitaxel-Eluting Stents for Treatment of STEMI: A HORIZONS-AMI Substudy. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 3rd, 2011

25. BEPM Claessen, GW Stone, R Mehran, B Witzenbichler, B Brodie, W Ruzyllo, K Zmudka, G Guagliumi, J Wohrle, K Huber, J Kochman, F Hartmann, G Syros, I Apostolidou, S Leon, GD Dangas. Relationship between Biomarkers and Subsequent Adverse Ischemic and Bleeding Events after ST-Elevation Myocardial Infarction: A HORIZONS-AMI Substudy. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 3rd, 2011

26. BEPM Claessen, R Mehran, K Obunai, C Godino, A Chieffo, GD Dangas, M Carlino, YH Kim, C Dimario, SJ Park, GW Stone, A Colombo, JW Moses, MB Leon, on behalf of the Multinational CTO Registry. Procedural and Long-Term Clinical Outcomes after Percutaneous Coronary Intervention of Chronic Total Occlusions in Women: A Report from the Multinational CTO registry. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 5th, 2011

27. BEPM Claessen, PC Smits, DJ Kereiakes, E Kedhi, M Fahy, PW Serruys, GW Stone. Two-Year Outcomes with Everolimus-Eluting Stents vs. Paclitaxel-Eluting Stents According to Lesion Length and Vessel Diameter: Pooled Analysis from the SPIRIT II, III, IV and COMPARE Randomized Trials. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 3rd, 2011

28. BEPM Claessen, GW Stone, R Mehran, B Witzenbichler, B Brody, W Ruzyllo, K Zmudka, G Guagliumi, J Wohrle, K Huber, J Kochman, F Hartmann, E Sanidas, D Hakim, V Chantziara, S leon, GD Dangas. Clinical Utility of Biomarkers to Predict Stent Thrombosis after STEMI Treated with DES: A HORIZONS-AMI substudy with 3-year follow-up. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 4th, 2011

29. R Mehran, BEPM Claessen, GD Dangas, JW Suh, H Parise, AJ Lansky, B Witzenbichler, CL Grines, G Guagliumi, R Kornowski, J Wohrle, D Dudek, G Weisz, JW Moses, GW Stone. Discharge Medication Use in Patients who Experience Bleeding Complications after Primary PCI: Analysis from HORIZONS-AMI. JACC, supplement, 2011, in print. Poster, presented at ACC, New Orleans, April 3rd, 2011

30. BEPM Claessen, R Mehran, GW Stone, B Witzenbichler, B Brodie, W Ruzyllo, K Zmudka, G Guagliumi, J Wohrle, K Huber, J Kochman, F Hartmann, G Syros, I Apostolidou, S Leon, GD Dangas. Clinical Utility of Biomarkers to Predict Major Bleeding Events after STEMI: A HORIZONS-AMI substudy with 3-year follow-up. CCI Supplement, in print. Poster, presented at SCAI 2011 Scientific Sessions, Baltimore, May 4th, 2011.

31. BEPM Claessen, G Weisz, GD Dangas, A Colombo, SJ Park, JW Moses, C DiMario, GW Stone, B Witzenbichler, R Mehran. Impact of TIMI 0/1 flow in non-infarct related arteries in patients with ST-elevation myocardial infarction on myocardial blush and long-term mortality: three-year results from the HORIZONS-AMI trial. Poster, presented at ESC, Paris, August 29th, 2011

32. BEPM Claessen, JW Suh, GD Dangas, K Obunai, C Godino, JH Kim, C DiMario, A Colombo, SJ Park, R Mehran. Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients: five-year outcomes from a 1,791 patient multi-national registry. Poster, presented at ESC, Paris, August 30th, 2011

33. BEPM Claessen, R Mehran, GW Stone, B Witzenbichler, B Brodie, W Ruzyllo, K Zmudka, G Guagliumi, J Wohrle, K Huber, J Kochman, F Hartmann, G Syros, I Apostolidou, S Leon, GD Dangas. Biomarkers to Predict Contrast Induced Nephropathy after Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A HORIZONS-AMI substudy. Poster, presented at TCT, San Francsico, November 8th, 2011

34. LP Hoebers, BEPM Claessen, WJ Kikkert, MM Vis, KT Koch, J Baan, JGP Tijssen, RJ de Winter, JJ Piek, JPS Henriques.The Impact of the Location of a Chronic Total Occlusion in Conjunction with the Location of the Infarct Related Artery on Long-Term Mortality in ST-Elevation Myocardial Infarction Patients. Poster, presented at TCT, San Francsico, November 8th, 2011

35. EA Sanidas, A Maehara, GS Mintz, T Kubo, A Gupta, BEPM Claessen, D Hakim, R Rusinova, G Weisz, MA Apfelbaum, MB Leon, M Fahy, JW Moses, D Mancini, LE Rabbani. Volumetric Intravascular Ultrasound Assessment Of Mechanisms and Results Of Stent Expansion In Heart Transplant Patients. Poster, presented at TCT, San Francsico, November 8th, 2011

36. BEPM Claessen, GD Dangas, G Weisz, B Witzenbichler, G Guagliumi, M Möckel, K Xu, JPS Henriques, R Mehran, GW Stone. Prognostic Impact of a Chronic Total Occlusion in a Non-Infarct Related artery in Patients with ST-segment Elevation Myocardial Infarction: Three-Year results from the HORIZONS-AMI Trial. Poster, presented at TCT, San Francsico, November 8th, 2011

37. J Yu, GD Dangas, S Sartori, BEPM Claessen, M Fahy, H Parise, AJ Lansky, B Witzenbichler, CL Grines, G Guagliumi, R Kornowski, J Wohrle, D Dudek, GW Stone, R Mehran.Do Geographic Trends in Aspirin Discharge Dose Alter Outcomes After STEMI and Primary PCI: Results From the HORIZONS-AMI Trial Poster, presented at AHA scientific sessions, Orlando, November 16th, 2011

38. R Jarai, GD Dangas, K Huber, K Xu, R Mehran, GW Stone, BEPM Claessen. B-Type Natriuretic Peptide and the Risk of Contrast Induced Nephropathy in STEMI: Analysis from the HORIZONS-AMI Trial. Moderated Poster, presented at ACC Scientific Sessions, Chicago, March 25th, 2012

39. LP Hoebers, BEPM Claessen, GD Dangas, SJ Park, JW Moses, A Colombo, JPS Henriques, GW Stone, MB Leon, R Mehran, on behalf of the multinational CTO registry. Long-Term Clinical Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions in Elderly Patients (≥75 years): Five-Year Outcomes from a 1,791 Patient Multi-National Registry. Poster, presented at TCT, Miami, October 23rd, 2012

40. BEPM Claessen, GD Dangas, R Mehran, Ke XU, GW Stone. Stent Thrombosis after Primary Angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy overtime; Results of the HORIZONS-AMI trial. Poster, presented at TCT, Miami, October 23rd, 2012

41. BEPM Claessen, G Syros, R Mehran, AE Sanidas, V Chantziara, I Apostolidou, G Weisz, L Rabbani, C Hooper, G Dangas. Impact of Multiple Polymorphisms on Clinical Outcomes after Percutaneous Coronary Interventions, Poster, presented at ESC, Amsterdam, September 3rd, 2013

42. WJ Kikkert, LP Hoebers, P Damman, KVV Lieve, BEPM Claessen, MM Vis, J Baan, KT Koch, RJ de Winter, JJ Piek, JGP Tijssen, JPS Henriques. Recurrent Myocardial Infarction after Primary Percutaneous Coronary Intervention for Acute ST-segment Elevation Myocardial Infarction. Poster, presented at ESC, Amsterdam, September 1st, 2013

Prof. MD PhD J.P. Simao Henriques (Low circulatory output in acute coronary syndromes)

• T.P.W. van den Boogert